Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The study aims to observe the incidence of serious adverse
drug reactions in patients with type 2 diabetes during NovoMix® 30 treatment.